https://www.selleckchem.com/pr....oducts/l-mimosine.ht
for orphan medicines, based on a sound methodology to measure these data and to compare them internationally. A low number of studies that informed about pharmaceutical spending on orphan medicines was published, thereof only a few explicitly analysed expenditure data of public payers. A conclusive synthesis of public spending on orphan medicines is a challenge given to the diversity in methodologies to measure expenditure. There is a need for further research to survey primary data of public spending for orphan medicines, based on a
Like
Comment
Share
